Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Hypothesis/Commentary

Provocative Questions in Cancer Epidemiology in a Time of Scientific Innovation and Budgetary Constraints

Tram K. Lam, Sheri D. Schully, Scott Rogers, Rachel Benkeser, Britt C. Reid reidbr@mail.nih.gov and Muin J. Khoury
Tram K. Lam
1Division of Cancer Control and Population Sciences, NIH/NCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lamt@mail.nih.gov
Sheri D. Schully
1Division of Cancer Control and Population Sciences, NIH/NCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Rogers
2EGRP, NCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Benkeser
1Division of Cancer Control and Population Sciences, NIH/NCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Britt C. Reid reidbr@mail.nih.gov
2EGRP, NCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muin J. Khoury
3Office of Public Health Genomics, CDC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-0101
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

In a time of scientific and technological developments and budgetary constraints, the National Cancer Institute (NCI)'s Provocative Questions (PQ) Project offers a novel funding mechanism for cancer epidemiologists. We reviewed the purposes underlying the PQ Project, present information on the contributions of epidemiologic research to the current PQ portfolio, and outline opportunities that the cancer epidemiology community might capitalize on to advance a research agenda that spans a translational continuum from scientific discoveries to population health impact.

  • Received January 28, 2013.
  • Revision received February 6, 2013.
  • Accepted February 7, 2013.
  • Copyright © 2013, American Association for Cancer Research.
Next
Back to top

This OnlineFirst version was published on February 14, 2013
doi: 10.1158/1055-9965.EPI-13-0101

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Provocative Questions in Cancer Epidemiology in a Time of Scientific Innovation and Budgetary Constraints
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Provocative Questions in Cancer Epidemiology in a Time of Scientific Innovation and Budgetary Constraints
Tram K. Lam, Sheri D. Schully, Scott Rogers, Rachel Benkeser, Britt C. Reid reidbr@mail.nih.gov and Muin J. Khoury
Cancer Epidemiol Biomarkers Prev February 14 2013 DOI: 10.1158/1055-9965.EPI-13-0101

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Provocative Questions in Cancer Epidemiology in a Time of Scientific Innovation and Budgetary Constraints
Tram K. Lam, Sheri D. Schully, Scott Rogers, Rachel Benkeser, Britt C. Reid reidbr@mail.nih.gov and Muin J. Khoury
Cancer Epidemiol Biomarkers Prev February 14 2013 DOI: 10.1158/1055-9965.EPI-13-0101
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • The Evolving Scale and Profile of Cancer
  • Physicians and HPV Vaccination
  • HPV Genotyping as Triage Marker
Show more Hypothesis/Commentary
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement